The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics

Journal of Cardiovascular Pharmacology

Volumn 8, Issue , 1986, Pages S74-S77

  Chatterjee, S S ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Asthmatics; Atenolol; Bisoprolol; Hypertension; 1 Selectivity

Indexed keywords

ATENOLOL; BISOPROLOL; NEW DRUG; PLACEBO; SALBUTAMOL;

ADULT; AGED; AIRWAY RESISTANCE; ASTHMA; BLOOD PRESSURE; CARDIOSELECTIVITY; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; DOSE RESPONSE; DRUG COMPARISON; DRUG EFFICACY; DRUG RECEPTOR BINDING; FORCED EXPIRATION; FORCED EXPIRATORY VOLUME; HEART; HEART RATE; HUMAN; HYPERTENSION; LUNG FUNCTION; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHARMACOLOGY; PRIORITY JOURNAL; RESPIRATORY SYSTEM; THERAPY; VITAL CAPACITY;

ADRENERGIC BETA-ANTAGONISTS; AGED; ALBUTEROL; ASTHMA; BISOPROLOL; BLOOD PRESSURE; BRONCHIAL PROVOCATION TESTS; FEMALE; HEART; HEART RATE; HUMAN; HYPERTENSION; HYPOTENSION; MALE; MIDDLE AGE; ORGAN SPECIFICITY; PROPANOLAMINES; RESPIRATORY FUNCTION TESTS; TIME FACTORS;

EID: 0022992002     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/00005344-198511001-00013     Document Type: Article

References (13)

1. 3H (±) carazolol binding to β-adrenergic receptors. Application to study of β-adrenergic receptor subtypes in canine ventricular myocardium and lung. Circ Res 1981;49:326-36.
2. 1-adrenoreceptor antagonist bisoprolol. Arzneimittelforsch 1986;36(I):200-8.
3. Schliep HJ, Schulze E, Harting J, Haeusler G. Antagonistic effects of bisoprolol on several β-adrenoceptor mediated actions in anaesthetized cats. Eur J Pharmacol 1986; 123:253-61.
4. Tattersfield AE, Cragg DJ, Bacon RJ. Assessment of β-adrenoceptor selectivity of a new β-adrenoceptor antagonist, bisoprolol, in man. Br J Clin Pharmacol 1984;18:343-7.
5. 1-selectivity of single doses of bisoprolol and atenolol. J Cardiovasc Pharmacol 1986;8(Suppl 11): S58-60.
6. Wellstein A, Palm D, Belz GG, Leopold G, Bühring KU, Pabst J. Concentration kinetics of propranolol, bisoprolol and atenolol in humans assessed with chemical detection and a subtype-selective β-adrenoceptor assay. J Cardiovasc Pharmacol 1986; 8(Suppl ll):S41-5.
7. Wellstein A, Palm D, Belz GG. Affinity and selectivity of β-adrenoceptor antagonists in vitro. J Cardiovasc Pharmacol 1986;8(Suppl ll):S36-40.
8. Dorow P, Tonnesmann U. Dose-response relationship of the β-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis. Eur J Clin Pharmacol 1984;27:135-9.
9. Dorow P, Bethge H, Tönnesmann U. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. Eur J Clin Pharmacol 1986;31:143-7.
10. Lammers JWJ, Folgering HThM, van Herwaarden CLA. Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients. J Cardiovasc Pharmacol 1986;8(Suppl ll):S69-73.
11. Bolli P, Müller FB, Linder L, Ji BH, Bühler FR. Cardiac and vascular β-adrenoceptor mediated responses before and during treatment with bisoprolol or atenolol. J Cardiovasc Pharmacol 1986;8(Suppl ll):S61-4.
12. Leopold G, Pabst J, Ungethiim W, Buhring KU. Basic pharmacokinetics of bisoprolol, a new highly beta,-selective adrenoceptor antagonist. J. Clin Pharmacol 1986;26:616-27.
13. Fitzgerald JD, Ruffin R, Smedstad KG, Roberts R, McAinsh J. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man. Eur J Clin Pharmacol 1978;13:81-9.